Chronic stable angina coronary angiography
Chronic stable angina Microchapters
Alternative Therapies for Refractory Angina
Guidelines for Asymptomatic Patients
Chronic stable angina coronary angiography On the Web
Coronary angiography is a gold standard test in the evaluation of severity of coronary artery disease and the possibility for revascularization. Coronary angiography is indicated in patients with a high pretest probability of CAD and in symptomatic patients with inconclusive initial noninvasive tests. Provocative testing with ergonovine during angiography may be useful in patients with vasospastic angina. Major complications such as death, MI and stroke associated with routine angiography is as low as 0.1% - 0.2%.
- When the probability of severe angina is low, noninvasive tests are more appropriate.
- When the pretest probability is high, direct referral for coronary angiography is a suitable choice.
- The principal indication for coronary angiography in patients with stable angina pectoris with or without previous myocardial infarction is the consideration of coronary revascularization.
- The demonstration of presence of one or more critical coronary artery stenosis does not necessarily indicate that they are the cause of a chest pain syndrome. Furthermore, typical angina pectoris can occur in the absence of obstructive atherosclerotic CAD, thus raising the question of the presence of vasospastic angina, the metabolic syndrome X, or non ischemic causes of chest pain.
- In patients with vasospastic angina diagnosed by noninvasive studies, coronary angiography is indicated to determine whether there is an underlying fixed coronary artery stenosis present in addition to the spasm. Most cases of Prinzmetal's angina occur superimposed upon underlying atherosclerotic plaque.
- The indications for coronary angiography in patients with walk through angina, mixed angina, and postprandial angina are similar to those in patients with chronic stable exertional angina.
- Coronary angiography is most useful in the following clinical scenarios:
- To exclude anatomical abnormalities in young patients as the cause of angina.
- If there is a failure to make a definitive diagnosis after noninvasive tests
- In patients with suspected coronary artery spasm who require provocative tests such as ergonovine
- Sudden cardiac death survivors
- Patient with medical conditions that limit or prevent performance of noninvasive tests.
- An increased probability of left main coronary artery stenosis or multi vessel disease.
- An occupational requirement to confirm or reject a diagnosis of coronary artery disease (e.g. airline pilots).
- Occasionally, coronary angiography is recommended for diagnostic purposes because the patient’s clinical presentation and noninvasive test results are inconclusive.
- In general, a stenosis of 50% or more of the luminal diameter, which corresponds to a reduction of 70% or more of the cross sectional area, is considered significant coronary artery disease (CAD), since stenosis of this severity reduces coronary blood flow with exercise even though more severe stenosis are required to reduce flow at rest.
- A 70% stenosis of luminal diameter corresponds to a 90% cross-sectional area stenosis, and may result in angina at rest.
- The extent of coronary artery disease (CAD) is often expressed in terms of the number of major epicardial coronary arteries with ≥50% diameter stenosis.
ACC/AHA/ACP–ASIM Guidelines for the Management of Patients With Chronic Stable Angina (DO NOT EDIT)
Coronary Angiography to Establish a Diagnosis in Patients With Suspected Angina, Including Those With Known CAD Who Have a Significant Change in Anginal Symptoms (DO NOT EDIT)
|"1. Patients with known or possible angina pectoris who have survived sudden cardiac death. (Level of Evidence: B)"|
|"1. Patients with significant comorbidity in whom the risk of coronary arteriography outweighs the benefit of the procedure. (Level of Evidence: C)"|
|"2. Patients with an overriding personal desire for a definitive diagnosis and a low probability of CAD. (Level of Evidence: C)"|
|"1. Patients with an uncertain diagnosis after noninvasive testing in whom the benefit of a more certain diagnosis outweighs the risk and cost of coronary angiography. (Level of Evidence: C)"|
|"2. Patients who cannot undergo noninvasive testing due to disability, illness, or morbid obesity. (Level of Evidence: C)"|
|"3. Patients with an occupational requirement for a definitive diagnosis. (Level of Evidence: C)"|
|"4. Patients who by virtue of young age at onset of symptoms, noninvasive imaging, or other clinical parameters are suspected of having a nonatherosclerotic cause of myocardial ischemia (coronary artery anomaly, Kawasaki disease, primary coronary artery dissection, radiation-induced vasculoplasty). (Level of Evidence: C)"|
|"5. Patients in whom coronary artery spasm is suspected and provocative testing may be necessary. (Level of Evidence: C)"|
|"6. Patients with a high pretest probability of left main or 3-vessel CAD. (Level of Evidence: C)"|
|"1. Patients with recurrent hospitalization for chest pain in whom a definite diagnosis is judged necessary. (Level of Evidence: C)"|
|"2. Patients with an overriding desire for a definitive diagnosis and a greater-than-low probability of CAD. (Level of Evidence: C)"|
ESC Guidelines- Coronary Arteriography for the Purposes of Establishing a Diagnosis in Stable Angina (DO NOT EDIT)
|"1. Severe stable angina (Class 3 or greater of Canadian Cardiovascular Society Classiﬁcation), with a high pre-test probability of disease, particularly if the symptoms are inadequately responding to medical treatment. (Level of Evidence: B)"|
|"2. Survivors of cardiac arrest. (Level of Evidence: B)"|
|"3. Patients with serious ventricular arrhythmias. (Level of Evidence: C)"|
|"4. Patients previously treated by myocardial revascularization (PCI, CABG) who develop early recurrence of moderate or severe angina pectoris. (Level of Evidence: C)"|
|"1. Patients with an inconclusive diagnosis on non-invasive testing, or conﬂicting results from different noninvasive modalities at intermediate to high risk of coronary artery disease. (Level of Evidence: C)"|
|"2. Patients with a high risk of restenosis after PCI if PCI has been performed in a prognostically important site. (Level of Evidence: C)"|
- ↑ Noto TJ, Johnson LW, Krone R, Weaver WF, Clark DA, Kramer JR et al. (1991) Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Cathet Cardiovasc Diagn 24 (2):75-83. PMID: 1742788
- ↑ 2.0 2.1 Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM et al. (1999). "ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina).". Circulation 99 (21): 2829-48. PMID 10351980.
- ↑ Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F et al. (2006). "Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.". Eur Heart J 27 (11): 1341-81. doi:10.1093/eurheartj/ehl001. PMID 16735367.
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies